Ovarian cancer and the immune system

por Baert, Thaïs, Vergote, Ignace, Coosemans, An
Publicado 2017

Dendritic cell-based immunotherapy in ovarian cancer

por Coosemans, An, Vergote, Ignace, Van Gool, Stefaan W
Publicado 2013

The dark side of ID8-Luc2: pitfalls for luciferase tagged murine models for ovarian cancer

por Baert, Thaïs, Verschuere, Tina, Van Hoylandt, Anaïs, Gijsbers, Rik, Vergote, Ignace, Coosemans, An
Publicado 2015

Tenckhoff tunneled peritoneal catheter placement in the palliative treatment of malignant ascites: technical results and overall clinical outcome

por Maleux, Geert, Indesteege, Inge, Laenen, Annouschka, Verslype, Chris, Vergote, Ignace, Prenen, Hans
Publicado 2016

Tumor Treating Fields (TTFields) Therapy Concomitant with Taxanes for Cancer Treatment

por Vergote, Ignace, Macarulla, Teresa, Hirsch, Fred R., Hagemann, Carsten, Miller, David Scott
Publicado 2023

Organoids of epithelial ovarian cancer as an emerging preclinical in vitro tool: a review

por Dumont, Sander, Jan, Ziga, Heremans, Ruben, Van Gorp, Toon, Vergote, Ignace, Timmerman, Dirk
Publicado 2019

Immunological configuration of ovarian carcinoma: features and impact on disease outcome

por Fucikova, Jitka, Coosemans, An, Orsulic, Sandra, Cibula, David, Vergote, Ignace, Galluzzi, Lorenzo, Spisek, Radek
Publicado 2021

Proteomic biomarkers predicting lymph node involvement in serum of cervical cancer patients. Limitations of SELDI-TOF MS

por Van Gorp, Toon, Cadron, Isabelle, Daemen, Anneleen, De Moor, Bart, Waelkens, Etienne, Vergote, Ignace
Publicado 2012

Reactive Nodular Fibrous Pseudotumor: Case Report and Review of the Literature

por Salihi, Rawand, Moerman, Philippe, Timmerman, Dirk, Van Schoubroeck, Dominique, Op de beeck, Katya, Vergote, Ignace
Publicado 2014

Intraperitoneal alpha therapy with (224)Ra-labeled microparticles combined with chemotherapy in an ovarian cancer mouse model

por Wouters, Roxanne, Westrøm, Sara, Berckmans, Yani, Riva, Matteo, Ceusters, Jolien, Bønsdorff, Tina B., Vergote, Ignace, Coosemans, An
Publicado 2022

Dysregulation of microRNAs in breast cancer and their potential role as prognostic and predictive biomarkers in patient management

por van Schooneveld, Eleni, Wildiers, Hans, Vergote, Ignace, Vermeulen, Peter B, Dirix, Luc Y, Van Laere, Steven J
Publicado 2015

Bowel obstruction in advanced tubo-ovarian cancer: a retrospective cohort study

por Jansen, Jolien, Oldenburger, Eva, Jansen, Jente, Wolthuis, Albert, Van Nieuwenhuysen, Els, Neven, Patrick, Vergote, Ignace, Han, Sileny N.
Publicado 2023

Loss of 1p36.33 Frequent in Low-Grade Serous Ovarian Cancer

por Van Nieuwenhuysen, Els, Busschaert, Pieter, Laenen, Annouschka, Moerman, Philippe, Han, Sileny N., Neven, Patrick, Lambrechts, Diether, Vergote, Ignace
Publicado 2019

Myeloid Derived Suppressor Cells: Key Drivers of Immunosuppression in Ovarian Cancer

por Baert, Thaïs, Vankerckhoven, Ann, Riva, Matteo, Van Hoylandt, Anaïs, Thirion, Gitte, Holger, Gerhardt, Mathivet, Thomas, Vergote, Ignace, Coosemans, An
Publicado 2019

Opposite Macrophage Polarization in Different Subsets of Ovarian Cancer: Observation from a Pilot Study

por Vankerckhoven, Ann, Wouters, Roxanne, Mathivet, Thomas, Ceusters, Jolien, Baert, Thaïs, Van Hoylandt, Anaïs, Gerhardt, Holger, Vergote, Ignace, Coosemans, An
Publicado 2020

Type of chemotherapy has substantial effects on the immune system in ovarian cancer

por Vankerckhoven, Ann, Baert, Thaïs, Riva, Matteo, De Bruyn, Christine, Thirion, Gitte, Vandenbrande, Katja, Ceusters, Jolien, Vergote, Ignace, Coosemans, An
Publicado 2021

High-grade endometrial stromal sarcoma presenting in a 28-year-old woman during pregnancy: a case report

por Amant, Frédéric, Van Calsteren, Kristel, Debiec-Rychter, Maria, Heyns, Liesbeth, De Beeck, Katya Op, Sagaert, Xavier, Bollen, Bart, Vergote, Ignace
Publicado 2010

Increased expression of placental growth factor in high-grade endometrial carcinoma

por COENEGRACHTS, LIEVE, SCHRAUWEN, STEFANIE, VAN BREE, RITA, DESPIERRE, EVELYN, LUYTEN, CATHERINE, JONCKX, BART, STASSEN, JEAN MARIE, VERGOTE, IGNACE, AMANT, FRÉDÉRIC
Publicado 2013

Preoperative HE4 and ROMA values do not improve the CA125 diagnostic value for borderline tumors of the ovary (BOT) – a study of the TOC Consortium

por Braicu, Elena Ioana, Van Gorp, Toon, Nassir, Mani, Richter, Rolf, Chekerov, Radoslav, Gasimli, Khayal, Timmerman, Dirk, Vergote, Ignace, Sehouli, Jalid
Publicado 2014

Effect of Particle Carriers for Intraperitoneal Drug Delivery on the Course of Ovarian Cancer and Its Immune Microenvironment in a Mouse Model

por Wouters, Roxanne, Westrøm, Sara, Vankerckhoven, Ann, Thirion, Gitte, Ceusters, Jolien, Claes, Sandra, Schols, Dominique, Bønsdorff, Tina B., Vergote, Ignace, Coosemans, An
Publicado 2022